Health authorities in India are monitoring new cases of Nipah virus after the World Health Organization confirmed two infections in an eastern Indian state on Thursday. The rare but deadly virus has alarmed public health officials due to its high fatality rate and lack of approved treatment.
Nipah virus is known to kill more than half of those it infects. Although it belongs to the same virus family as measles, it spreads far less easily. However, it is significantly more lethal. First identified in Malaysia in the late 1990s, the virus was named after the village where the earliest known patient lived. Since then, sporadic outbreaks have appeared across parts of Asia.
Experts say the newly reported cases highlight the ongoing threat posed by emerging zoonotic diseases. While outbreaks remain rare, the severity of illness and the virus’s ability to spread between people keep it under close international surveillance.
How Nipah Virus Is Transmitted
Nipah virus is classified as a zoonotic infection, meaning it can pass from animals to humans. According to the US Centers for Disease Control and Prevention, the most common sources of infection are fruit bats and pigs. Direct contact with infected animals remains the primary route of transmission.
In addition, people can become infected by consuming food contaminated with bat saliva or urine. Raw date palm sap and fruits exposed to bats have been linked to several outbreaks in South Asia. As a result, food safety practices play a critical role in prevention.
Person-to-person transmission can also occur, though it requires very close contact. Caregivers and family members are most at risk, particularly when infection control measures are limited. Despite this risk, Nipah virus does not spread as easily as airborne diseases like measles or influenza.
Early Symptoms and Disease Progression
Symptoms of Nipah virus typically appear between four and 14 days after exposure, according to the World Health Organization. Asymptomatic infections are rare, which makes early detection challenging.
Initially, patients often experience non-specific symptoms such as fever, headache, muscle pain, sore throat, and vomiting. These signs resemble common viral illnesses, which can delay diagnosis. However, in roughly two-thirds of patients, the disease progresses rapidly.
Within five to seven days, severe neurological complications may develop. Many patients slip into a coma, while others experience confusion, seizures, or altered consciousness. Respiratory symptoms, including coughing and abnormal chest imaging, have also been reported in some cases.
Why Nipah Virus Is Considered Highly Dangerous
Public health agencies classify Nipah virus as a biosafety level four pathogen. This category includes the most dangerous known viruses, such as Ebola. The classification reflects its high mortality rate, absence of approved treatments, and potential to cause outbreaks.
In severe cases, the virus attacks critical areas of the brain that regulate heart rate, blood pressure, and eye movement. This damage can lead to long-term neurological impairment or death. Survivors often face persistent fatigue and lasting changes to nervous system function.
Because of these risks, Nipah virus is also considered a potential bioterrorism agent. While such use remains theoretical, the classification underscores the seriousness with which health authorities approach each outbreak.
Read Also
The Mystery of Migraines
Intrusive Thoughts
How Fibre Boosts Health
Diagnosis and Medical Response to Nipah Virus
Diagnosing Nipah virus typically involves laboratory testing of blood samples. These tests detect and measure specific viral proteins to confirm infection. Due to limited availability of specialized laboratories, diagnosis can be delayed in remote areas.
At present, there is no vaccine or antiviral drug specifically approved to treat Nipah virus. Medical care focuses on supportive treatment, including hydration, fever management, and respiratory support. Patients with severe neurological symptoms often require intensive care and mechanical ventilation.
The antiviral drug ribavirin has been used experimentally in some outbreaks. Although it is approved for treating chronic hepatitis C in combination therapies, its effectiveness against Nipah virus remains uncertain. Studies have produced mixed results, and no definitive treatment protocol exists.
Where Nipah Virus Outbreaks Occur
Nipah virus outbreaks occur almost every year in parts of Asia. Bangladesh records the highest number of cases, followed by India, Malaysia, the Philippines, and Singapore. These regions are home to large fruit bat populations, which serve as natural reservoirs for the virus.
Transmission often peaks between December and May. This period coincides with bat breeding seasons and the harvesting of date palm sap, increasing opportunities for human exposure. As a result, seasonal surveillance is a key public health strategy.
Beyond South and Southeast Asia, Nipah virus has been detected in bats in countries such as China, Cambodia, Thailand, Madagascar, and Ghana. However, no human cases have ever been reported in the United States.
How Rare Is Nipah Virus Globally
Despite its severity, Nipah virus remains extremely rare. As of 2024, approximately 754 cases have been reported worldwide. Health experts believe this figure is likely underestimated due to limited surveillance and diagnostic capacity in some regions.
Even so, the virus’s high fatality rate and potential for human-to-human transmission keep it on the World Health Organization’s priority pathogen list. Each new case prompts swift public health responses, including contact tracing, isolation measures, and community education.
The latest cases in India reinforce the importance of early detection, infection control, and prevention strategies. While Nipah virus does not pose a widespread threat to the general public, health officials stress that vigilance remains essential wherever zoonotic diseases emerge.
